(Q39742239)

14 September 2017

title

Impact of a genetic variant in CYP3A4 on risk and clinical presentation of prostate cancer among white and African-American men. (English)

1 reference

14 September 2017

Dieudonne Bangsi

1

1 reference

14 September 2017

Junying Zhou

2

1 reference

14 September 2017

Yezhou Sun

3

1 reference

14 September 2017

Nimesh P Patel

4

1 reference

14 September 2017

Linda L Darga

5

1 reference

14 September 2017

Lance K Heilbrun

6

1 reference

14 September 2017

Isaac J Powell

7

1 reference

14 September 2017

Richard K Severson

8

1 reference

14 September 2017

Richard B Everson

9

1 reference

14 September 2017

publication date

1 January 2006

1 reference

14 September 2017

1 reference

14 September 2017

volume

24

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

21-27

1 reference

Genetic contribution to variable human CYP3A-mediated metabolism

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6 beta-hydroxylase cytochrome P-450 enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Single nucleotide primer extension to detect genetic diseases: experimental application to hemophilia B (factor IX) and cystic fibrosis genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Genotyping of two mutations in the HFE gene using single-base extension and high-performance liquid chromatography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Genotyping single nucleotide polymorphisms by primer extension and high performance liquid chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Re: Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Population distribution and effects on drug metabolism of a genetic variant in the 5' promoter region of CYP3A4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5'-upstream regulatory region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

CYP3A activity in African American and European American men: population differences and functional effect of the CYP3A4*1B5'-promoter region polymorphism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

CYP3A4 genetic variant and disease-free survival among white and black men after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.09.005

10.1016/J.UROLONC.2005.09.005

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference